On February 17, 2026, the U.S. Food and Drug Administration (FDA) approved FILKRI (filgrastim-laha), a biosimilar to Amgen’s NEUPOGEN (filgrastim). FILKRI was developed by Accord BioPharma, the U.S.

"The debate isn't about whether peptides work." The post Is It Safe to Inject Gray-Market Chinese Peptides? appeared first on Futurism.

A major study links Wegovy to a rare form of sudden vision loss, and finds men may face three times the risk of women.

Long-lasting treatment suppresses HIV in people with mental illness and other conditions that make it challenging to adhere ...

"In the delivery of medical care, and particularly for our care of neonates and young children, we must consider potential long-term implications of our decisions today," said Teresa Chapman, MD, MA, ...

Approval expands low-dose MRI contrast options for the youngest patients and reflects a positive benefit–risk profile of VUEWAY® injection from birth through adulthood PRINCETON, N.J., Feb. 23, 2026 ...

A recent small study has found that people may be able to maintain their weight loss with fewer GLP-1 injections, but this ...

Johra Kayeser Fatima receives funding from the ACT government. Jeroen van Boxtel has received funding from the ACT government, as well as from the Australian Research Council. Ram Subramanian received ...

As IL-6 inhibition comes into practice for PMR, research advances on other therapeutic mechanisms of action, from IL-17 to ...

Susvimo is an FDA-approved eye implant for diabetic macular edema that may reduce monthly injections to just two treatments a ...

A Florida woman accused of administering an illegal, fatal silicone injection into a Kim Kardashian lookalike was scheduled for a trial readiness conference and jury trial assignment on Friday after ...